GlassScriptPhysician profile
Nathaniel L Holzman
NPI 1053343582
$5,499.42
in general payments reported to CMS, 2019-2025
36 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $371 · 2021: $364 · 2022: $791 · 2023: $2,229 · 2024: $766 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.19 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,551.17 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mentor Worldwide LLC | $853.02 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Smith+Nephew, INC. | $681.64 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Organogenesis INC. | $319.07 | 2022-2023 | Puraply |
| Abbvie INC. | $285.41 | 2023-2025 | |
| Integra Lifesciences Corporation | $244.12 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Allergan, INC. | $136.01 | 2020-2022 | |
| Davol INC. | $132.92 | 2020-2024 | Arista Ah Flexitip, Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $118.17 | 2021-2024 | |
| Avita Medical Americas, LLC | $107.81 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Kci USA, INC. | $97.97 | 2019-2023 | V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac, Prevena |
| Coopersurgical, INC. | $90.64 | 2019-2020 | |
| Tela Bio, INC. | $88.28 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Lifenet Health | $84.26 | 2023-2025 | Theragenesis Wound Matrix |
| Sientra, INC. | $74.34 | 2020-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $70.56 | 2021-2022 | |
| Galderma Laboratories, L.P. | $67.81 | 2021-2025 | |
| Urgo Medical North America, LLC | $56.12 | 2023-2025 | Urgoclean Ag, Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Misonix INC | $55.00 | 2019-2021 | |
| Solventum Corporation | $43.68 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, 3m Cavilon |
| Reapplix INC. | $42.93 | 2023 | 3c Patch Kit - Box |
| Ethicon US, LLC | $32.57 | 2019 | |
| Reddress USA, INC. | $24.13 | 2023 | |
| Medline Industries LP | $23.99 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.92 | 2024 | Exparel |
| Revance Therapeutics, INC. | $22.67 | 2025 | Daxxify |
| Regeneron Healthcare Solutions, INC. | $22.33 | 2024 | Libtayo |
| Acera Surgical, INC. | $22.11 | 2024 | Restrata Wound Matrix |
| Zyla Life Sciences, INC. | $19.25 | 2020 | |
| W. L. Gore & Associates, INC. | $17.84 | 2022 | |
| Sanara Medtech INC. | $16.72 | 2023 | Celleraterx |
| Acell, INC. | $16.57 | 2019 | |
| Tei Biosciences INC | $15.60 | 2019 | |
| Aroa Biosurgery Incorporated | $14.37 | 2022 | |
| Innocoll Pharmaceuticals Limited | $13.97 | 2021 | |
| Wright Medical Technology, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Holzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.